COMP <GO>
GRAL vs UNH // OPERATING MARGIN
GRAIL Inc. (NASDAQ) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: GRAL 3
— UNH 9
▲ OPERATING MARGIN LEADER: UNH
LAST: $139.44 (+4.25%) • MKT CAP: $5.97B
operating-margins
-60.00%
LAST: $404.44 (+1.00%) • MKT CAP: $359.43B
operating-margins
5.32%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (GRAL VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | GRAL | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 88.31% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -18.00% | 12.38% | -30.38 | UNH | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 15.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -4.23% | 6.25% | -10.48 | UNH | /fcf-yield <GO> |
| Operating Margin ACTIVE | -60.00% | 5.32% | -65.32 | UNH | /operating-margins <GO> |
| Net Profit Margin | -60.00% | 3.53% | -63.53 | UNH | /net-margins <GO> |
| Revenue Growth (YoY) | 17.20% | 3.33% | +13.87 | GRAL | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.29% | -2.29 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 7.26 | 3.09 | +4.17 | GRAL | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 7/9 | -1.00 | UNH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 7.00% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 49.0 | 55.1 | -6.10 | UNH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.00 | 0.33 | +0.67 | GRAL | /macro-sensitivity <GO> |
| Forward P/E Multiple | 22.0x | 17.7x | +4.26 | UNH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.97B | $359.43B | -$353.46B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | GRAL REV | UNH REV | GRAL GROSS % | UNH GROSS % | GRAL FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $147.2M | $447.57B | — | 88.7% | -$299.9M | $16.07B |
| FY 2024 | $125.6M | $400.28B | — | 88.3% | -$582.4M | $20.70B |
| FY 2023 | $93.1M | $371.62B | — | 89.6% | -$600.0M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
GRAL // BETA 1.00
UNH // BETA 0.33